Medical Bulletin 16/January/2023 Isra Zaman16 Jan 2023 10:00 AM GMTHere are the top medical news for the day:Novel drug combination therapy may treat often fatal childhood brain tumorThe most common malignant...
New approach for treating lupus holds promise, finds study Isra Zaman16 Jan 2023 4:00 AM GMTLupus, including SLE, occurs when the immune system attacks a person's own healthy tissues, causing pain, inflammation and tissue damage. Lupus most...
Medical Bulletin 4/January/2022 Isra Zaman4 Jan 2023 9:30 AM GMTHere are the top medical news for the day:APS perceived their physical and cognitive function to be less than optimal: StudyAntiphospholipid syndrome...
APS perceived their physical and cognitive function to be less than optimal: Study Isra Zaman4 Jan 2023 3:45 AM GMTAntiphospholipid syndrome or APS is characterized by persistently positive antiphospholipids antibodies in the setting of adverse obstetric events or...
People with autoimmune disease more likely to develop cardiac complications after MI Dr. Kamal Kant Kohli26 Dec 2022 2:30 PM GMTAutoimmune diseases, such as rheumatoid arthritis, systemic lupus erythematosis and psoriasis, are known to increase risk of cardiovascular disease,...
Anifrolumab promising for patients with moderate to severe lupus: reveals Longest SLE trial Dr. Kamal Kant Kohli17 Nov 2022 2:30 PM GMTUSA: Systemic lupus erythematosus (SLE) is a chronic autoimmune disease characterized by multisystem involvement ranging from mild to life-threatening...
Deucravacitinib treatment beneficial for patients with active lupus: Study Dr. Kamal Kant Kohli14 Nov 2022 2:15 PM GMTUSA: A recent study in Wiley's Arthritis & Rheumatology has shown promising results for deucravacitinib in patients with active lupus....
Medical Bulletin 14/November/2022 Isra Zaman14 Nov 2022 10:19 AM GMTHere are the top medical news for the day:Probiotic 'backpacks' as a potential treatment for inflammatory bowel diseasesLike elite firefighters headed...
Anifrolumab and deucravacitinib combo shows promise in patients with lupus Isra Zaman14 Nov 2022 4:00 AM GMTType I interferon (IFN) is a powerful immune activator that is present at high levels in the majority of patients with lupus, an autoimmune disease....
Childhood Systemic Lupus Erythematosus: IAP Guidelines Ayesha13 Aug 2022 5:30 AM GMTChildhood Systemic Lupus Erythematosus (cSLE) is a chronic heterogeneous autoimmune disease associated with considerable morbidity and significant...
Genotype linked to azathioprine discontinuation in patients with lupus and IBD Dr. Kamal Kant Kohli22 Jun 2022 4:30 AM GMTResearchers have found in a new study that Genotype is linked to azathioprine discontinuation in patients with lupus and IBD.The retrospective cohort...
Low-dose prednisolone effective for remission of lupus nephritis: Study Medha Baranwal28 Dec 2021 3:30 AM GMTBangladesh: A low-dose prednisolone regimen may be effective for the treatment of proliferative lupus nephritis (LN), indicates a recent study...
